BBNX files Rule 144 to sell 275 shares

BBNX filed a Rule 144 notice listing an equity award of 275 shares to be sold for cash, dated 06/01/2026 with a filing date of 06/04/2026.

Rhea-AI Filing Summary

BBNX filed a Rule 144 notice listing an equity award of 275 shares to be sold for cash, dated 06/01/2026 with a filing date of 06/04/2026.

The filing also discloses recent sales by Mark Hopman of 5,329 shares on 06/02/2026 for $68,157.91 and 353 shares on 03/04/2026 for $4,084.21. Shares outstanding are listed as 44,024,631 as of 06/04/2026.

Insights

Securities Counsel

Routine Rule 144 notice for the resale of restricted shares; prior small sales are reported.

Rule 144 paperwork lists an equity award of 275 shares intended for sale on 06/01/2026 and records prior dispositions by Mark Hopman totaling 5,682 shares across two dates. The filing ties the action to cash proceeds.

Timing and clearance mechanics are not detailed here; subsequent broker confirmations or Form 4/Form 144 updates would show settlement and method. Future filings may report completion or additional holder sales.

Key Figures

Shares to be sold (equity award): 275 shares Previous sale by Mark Hopman: 5,329 shares Previous sale by Mark Hopman: 353 shares +4 more

7 metrics

Shares to be sold (equity award) 275 shares equity award dated <date>06/01/2026

Previous sale by Mark Hopman 5,329 shares sold on <date>06/02/2026 for <money>$68,157.91</money>

Previous sale by Mark Hopman 353 shares sold on <date>03/04/2026 for <money>$4,084.21</money>

Shares outstanding 44,024,631 shares as of <date>06/04/2026</date>

Filing date 06/04/2026 form entry date

Reported cash proceeds (06/02/2026) $68,157.91 proceeds from 5,329-share sale on <date>06/02/2026</date>

Reported cash proceeds (03/04/2026) $4,084.21 proceeds from 353-share sale on <date>03/04/2026</date>

Key Terms

Rule 144, Equity Award, Shares outstanding

3 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Equity Award financial

"Common | 06/01/2026 | Equity Award | issuer"

An equity award is a form of pay where a company gives employees, executives or other stakeholders the right to own or buy company shares—either immediately or after meeting certain conditions. Think of it like receiving slices of the company pie now or coupons to claim slices later; it matters to investors because it affects ownership dilution, executive incentives and reported compensation costs, and signals how management is being rewarded and retained.

Shares outstanding financial

"44024631 | 06/04/2026"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BBNX's Rule 144 filing report?

It reports an equity award of 275 shares proposed for sale for cash, dated 06/01/2026. The filing also lists recent affiliate dispositions by Mark Hopman on 06/02/2026 and 03/04/2026.

How many shares did Mark Hopman recently sell per the filing?

The filing shows Mark Hopman sold 5,329 shares on 06/02/2026 for $68,157.91 and 353 shares on 03/04/2026 for $4,084.21. Those amounts are reported as past three months activity.

How many shares does the filing list as outstanding for BBNX?

The filing lists 44,024,631 shares outstanding as of 06/04/2026. That figure is presented on the form and serves as the baseline outstanding share count in this excerpt.

Does the filing state how the 275 shares will be sold?

The filing indicates the 275 shares derive from an equity award and are to be sold for cash, dated 06/01/2026. No additional distribution method or broker details appear in the provided excerpt.

Will BBNX receive proceeds from the 275-share sale?

The excerpt labels the 275-share item as an equity award, issuer and notes the sale is for cash. The filing does not further describe proceeds allocation or use beyond that label in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 02:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002048497
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Beta Bionics, Inc.
SEC File Number	001-42491
Address of Issuer	11 HUGHES Irvine CALIFORNIA 92618
Phone	9494277785
Name of Person for Whose Account the Securities are To Be Sold	Mark Hopman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 6002 El Tordo 2nd FL PO Box 7297 Rancho Santa Fe CA 92067	275	3385.25	44024631	06/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Equity Award	issuer			275	06/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Hopman 11 HUGHES Irvine CA 92618	Common	06/02/2026	5329	68157.91
Mark Hopman 11 HUGHES Irvine CA 92618	Common	03/04/2026	353	4084.21

144: Remarks and Signature

Remarks
Date of Notice	06/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mark Hopman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)